Dividend compounder review

REGN

Regeneron Pharmaceuticals Inc · NASDAQ · US

Healthcare · Biotechnology

Chart Factor Intelligence Back to Screener

Score61.80/100

Confidence100.00/100

DecisionReject

RatingWeak Candidate

Scoring

Quality breakdown

Dividend Reliability 5.8 / 25 Payment history, cuts, growth, and regularity.

Dividend Sustainability 17.0 / 20 Payout, free cash flow, dividend cover, and debt.

Business Quality 24.0 / 25 Scale, cash generation, growth, margins, and returns.

Valuation Discipline 12.0 / 15 Yield, P/E, and price stretch versus long-term trend.

Long-Term Trend 3.0 / 15 Trend line, long return history, and drawdown control.

Metrics

Dividend Years1

Dividend Yield0.61%

Payout Ratio8.7%

Dividend Cut 5YNo

Net Income$4.5B

Free Cash Flow$3.8B

FCF Covers DividendYes

Debt / Equity8.61

P/E14.9

Revenue Growth 5Y11.0%

Net Margin29.6%

ROE14.5%

Price vs Trend-16.8%

3Y Return-20.8%

5Y Return12.1%

CurrencyUSD

Warnings

Dividend history is short: 1 completed years.

Debt to equity is elevated at 8.61.

Dividend diary